Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, et al.
Blood Advances
|
December 1, 2022
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
Afaf E G Osman, Nuria Mencia-Trinchant, Caner Saygin, et al.
American Journal of Hematology
|
August 11, 2020
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Caner Saygin, Karilyn Larkin, James S Blachly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results
Matthew J Wieduwilt, Jun Yin, Oudom Kour, et al.
Cancer Research
|
September 21, 2017
New Advances and Challenges of Targeting Cancer Stem Cells
Nurmaa K Dashzeveg, Rokana Taftaf, Erika K Ramos, et al.
Molecular Cancer
|
June 9, 2024
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer
Rashmi Bharti, Goutam Dey, Debjit Khan, et al.
Nature Communications
|
February 10, 2018
Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase
Praveena S Thiagarajan, Maksim Sinyuk, Soumya M Turaga, et al.
Blood Advances
|
December 24, 2019
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
Caner Saygin, Ashwin Kishtagari, Ryan D Cassaday, et al.
The Journal of Experimental Medicine
|
August 26, 2017
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Caner Saygin, Andrew Wiechert, Vinay S Rao, et al.
Blood
|
April 8, 2026
Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysis
Morgan Drucker, Darren Lee, Michael S Bowman, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
Caner Saygin, Giorgia Giordano, Kathryn Shimamoto, et al.
Blood Advances
|
December 1, 2022
Paired bone marrow and peripheral blood samples demonstrate lack of widespread dissemination of some CH clones
Afaf E G Osman, Nuria Mencia-Trinchant, Caner Saygin, et al.
American Journal of Hematology
|
August 11, 2020
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome
Caner Saygin, Karilyn Larkin, James S Blachly, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2025
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results
Matthew J Wieduwilt, Jun Yin, Oudom Kour, et al.
Cancer Research
|
September 21, 2017
New Advances and Challenges of Targeting Cancer Stem Cells
Nurmaa K Dashzeveg, Rokana Taftaf, Erika K Ramos, et al.
Molecular Cancer
|
June 9, 2024
Cell surface CD55 traffics to the nucleus leading to cisplatin resistance and stemness by inducing PRC2 and H3K27 trimethylation on chromatin in ovarian cancer
Rashmi Bharti, Goutam Dey, Debjit Khan, et al.
Nature Communications
|
February 10, 2018
Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase
Praveena S Thiagarajan, Maksim Sinyuk, Soumya M Turaga, et al.
Blood Advances
|
December 24, 2019
Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes
Caner Saygin, Ashwin Kishtagari, Ryan D Cassaday, et al.
The Journal of Experimental Medicine
|
August 26, 2017
CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors
Caner Saygin, Andrew Wiechert, Vinay S Rao, et al.
Blood
|
April 8, 2026
Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysis
Morgan Drucker, Darren Lee, Michael S Bowman, et al.
Page
of 7